197 related articles for article (PubMed ID: 9374415)
1. Intracellular targets for antidiabetic sulfonylureas and potassium channel openers.
Szewczyk A
Biochem Pharmacol; 1997 Nov; 54(9):961-5. PubMed ID: 9374415
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels.
Ashcroft FM; Gribble FM
J Diabetes Complications; 2000; 14(4):192-6. PubMed ID: 11004427
[TBL] [Abstract][Full Text] [Related]
3. Ion channel effects of antidiabetic sulfonylureas.
Lazdunski M
Horm Metab Res; 1996 Sep; 28(9):488-95. PubMed ID: 8911986
[TBL] [Abstract][Full Text] [Related]
4. ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release.
Bernardi H; De Weille JR; Epelbaum J; Mourre C; Amoroso S; Slama A; Fosset M; Lazdunski M
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1340-4. PubMed ID: 8433992
[TBL] [Abstract][Full Text] [Related]
5. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic and extrapancreatic sulfonylurea receptors.
Panten U; Schwanstecher M; Schwanstecher C
Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
[TBL] [Abstract][Full Text] [Related]
8. K+ channel openers activate brain sulfonylurea-sensitive K+ channels and block neurosecretion.
Schmid-Antomarchi H; Amoroso S; Fosset M; Lazdunski M
Proc Natl Acad Sci U S A; 1990 May; 87(9):3489-92. PubMed ID: 2333295
[TBL] [Abstract][Full Text] [Related]
9. KATP channel openers: structure-activity relationships and therapeutic potential.
Mannhold R
Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
[TBL] [Abstract][Full Text] [Related]
10. [ATP-sensitive potassium channels and substances affecting them].
Pospísilová Y
Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
[TBL] [Abstract][Full Text] [Related]
11. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of the glycaemic effects of sulfonylureas.
Ashcroft FM
Horm Metab Res; 1996 Sep; 28(9):456-63. PubMed ID: 8911983
[TBL] [Abstract][Full Text] [Related]
13. ATP-regulated K+ channel in mitochondria: pharmacology and function.
Szewczyk A; Czyz A; Wojcik G; Wojtczak L; Nalecz MJ
J Bioenerg Biomembr; 1996 Apr; 28(2):147-52. PubMed ID: 9132413
[TBL] [Abstract][Full Text] [Related]
14. Misunderstandings and controversies about the insulin-secreting properties of antidiabetic sulfonylureas.
Henquin JC
Biochimie; 2017 Dec; 143():3-9. PubMed ID: 28711685
[TBL] [Abstract][Full Text] [Related]
15. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
Remedi MS; Nichols CG
PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
[TBL] [Abstract][Full Text] [Related]
16. [Mitochondrial ion channels].
Debska G; Kicińska A; Skalska J; Berest V; Szewczyk A
Postepy Hig Med Dosw; 2002; 56(3):315-21. PubMed ID: 12194244
[TBL] [Abstract][Full Text] [Related]
17. Function, regulation, pharmacology, and molecular structure of ATP-sensitive K+ channels in the cardiovascular system.
Isomoto S; Kurachi Y
J Cardiovasc Electrophysiol; 1997 Dec; 8(12):1431-46. PubMed ID: 9436781
[TBL] [Abstract][Full Text] [Related]
18. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
19. Adenosine triphosphate-sensitive potassium (K(ATP)) channel activity is coupled with insulin resistance in obesity and type 2 diabetes mellitus.
Wasada T
Intern Med; 2002 Feb; 41(2):84-90. PubMed ID: 11868613
[TBL] [Abstract][Full Text] [Related]
20. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.
Horie M; Ishida-Takahashi A; Ai T; Nishimoto T; Tsuura Y; Ishida H; Seino Y; Sasayama S
Cardiovasc Res; 1997 Apr; 34(1):69-72. PubMed ID: 9217874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
